1. Home
  2. ETNB vs JBI Comparison

ETNB vs JBI Comparison

Compare ETNB & JBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • JBI
  • Stock Information
  • Founded
  • ETNB 2018
  • JBI 2002
  • Country
  • ETNB United States
  • JBI United States
  • Employees
  • ETNB N/A
  • JBI N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • JBI Building Products
  • Sector
  • ETNB Health Care
  • JBI Industrials
  • Exchange
  • ETNB Nasdaq
  • JBI Nasdaq
  • Market Cap
  • ETNB 1.5B
  • JBI 1.2B
  • IPO Year
  • ETNB 2019
  • JBI N/A
  • Fundamental
  • Price
  • ETNB $9.59
  • JBI $9.14
  • Analyst Decision
  • ETNB Strong Buy
  • JBI Buy
  • Analyst Count
  • ETNB 8
  • JBI 6
  • Target Price
  • ETNB $26.43
  • JBI $9.80
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • JBI 989.3K
  • Earning Date
  • ETNB 08-08-2025
  • JBI 08-07-2025
  • Dividend Yield
  • ETNB N/A
  • JBI N/A
  • EPS Growth
  • ETNB N/A
  • JBI N/A
  • EPS
  • ETNB N/A
  • JBI 0.35
  • Revenue
  • ETNB N/A
  • JBI $919,800,000.00
  • Revenue This Year
  • ETNB N/A
  • JBI N/A
  • Revenue Next Year
  • ETNB N/A
  • JBI $5.69
  • P/E Ratio
  • ETNB N/A
  • JBI $25.81
  • Revenue Growth
  • ETNB N/A
  • JBI N/A
  • 52 Week Low
  • ETNB $4.16
  • JBI $5.99
  • 52 Week High
  • ETNB $11.84
  • JBI $15.24
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 41.01
  • JBI 60.43
  • Support Level
  • ETNB $9.82
  • JBI $8.37
  • Resistance Level
  • ETNB $10.48
  • JBI $9.23
  • Average True Range (ATR)
  • ETNB 0.49
  • JBI 0.28
  • MACD
  • ETNB -0.14
  • JBI 0.01
  • Stochastic Oscillator
  • ETNB 3.70
  • JBI 75.74

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

Share on Social Networks: